Evidence map›Paper›PMID 26083576›Full record

ArticlePloS one2015

Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.

Hongfei Ge, Jonitha Gardner, Xiaosu Wu, Ingrid Rulifson, Jinghong Wang, Yumei Xiong, Jingjing Ye, Edward Belouski, Ping Cao, Jie Tang and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TFF3 as a Diagnostic Biomarker in Kidney Transplant Patients.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gastric epithelial histology and precancerous conditions.World journal of gastrointestinal oncology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Effect of Tff3 Deficiency and ER Stress in the Liver.International journal of molecular sciences · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Hongfei GeAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Jonitha GardnerAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Xiaosu WuAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Ingrid RulifsonAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Jinghong WangAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Yumei XiongAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Jingjing YeAmgen, Protein Technologies, South San Francisco, California, United States of America.
Edward BelouskiAmgen, Protein Technologies, South San Francisco, California, United States of America.
Ping CaoAmgen, Protein Technologies, South San Francisco, California, United States of America.
Jie TangAmgen, Protein Technologies, South San Francisco, California, United States of America.
Ki Jeong LeeAmgen, Lead Discovery, Thousand Oaks, California, United States of America.
Suzanne CoberlyAmgen, Pathology, South San Francisco, California, United States of America.
Xinle WuAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Jamila GupteAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Lynn MiaoAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Li YangAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Natalie NguyenAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Bei ShanAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Wen-Chen YehAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Murielle M VéniantAmgen, Metabolic Disorders, Thousand Oaks, California, United States of America.
Yang LiAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Helene BaribaultAmgen, Metabolic Disorders, South San Francisco, California, United States of America.
Amgen (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trefoil factor 3 (TFF3), also called intestinal trefoil factor or Itf, is a 59 amino acid peptide found as a homodimer predominantly along the gastrointestinal tract and in serum. TFF3 expression is elevated during gastrointestinal adenoma progression and has been shown to promote mucosal wound healing. Here we show that in contrast to other trefoil factor family members, TFF1 and TFF2, TFF3 is highly expressed in mouse duodenum, jejunum and ileum and that its expression is regulated by food intake. Overexpression of TFF3 using a recombinant adeno-associated virus (AAV) vector, or daily administration of recombinant TFF3 protein in vivo improved glucose tolerance in a diet-induced obesity mouse model. Body weight, fasting insulin, triglyceride, cholesterol and leptin levels were not affected by TFF3 treatment. Induction of mucinous metaplasia was observed in mice with AAV-mediated TFF3 overexpression, however, no such adverse histological effect was seen after the administration of recombinant TFF3 protein. Altogether these results suggest that the therapeutic potential of targeting TFF3 to treat T2D may be limited.

Indexed as

AnimalsBlood GlucoseCholesterolDependovirusDiet, High-FatDuodenumEatingGene ExpressionGene Expression RegulationGenetic VectorsGlucose Tolerance TestHumansIleumInsulinJejunumLeptinBlood GlucoseCholesterolInsulinLeptinMucinsRecombinant ProteinsTFF2 protein, humanTff3 protein, mouseTrefoil Factor-2Trefoil Factor-3Triglycerides

Identifiers

PMID26083576
PMCPMC4471263
OpenAlexW1484795140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.